(鈭?-Epigallocatechin-3-gallate (EGCG) modulates neurological function when intravenously infused in acute and, chronically injured spinal cord of adult rats
详细信息    查看全文
文摘
Spinal cord injury (SCI) causes severe and long lasting motor and sensory deficits, chronic pain, and autonomic dysreflexia. (鈭?-epigallocatechin-3-gallate (EGCG) has shown to produce neuroprotective effect in a broad range of neurodegenerative disease animal models. This study designed to test the efficacy of intravenous infusion of EGCG for 36聽h, in acutely injured rats' spinal cord: within first 4聽h post-injury and, in chronically SC injured rats: after one year of injury. Functional outcomes measured using standard BBB scale, The Louisville Swim Scale (LSS) and, pain behavior assessment tests. 72 Female adult rats subjected to moderate thoracic SCI using MASCIS Impactor, blindly randomized as the following: (I) Acute SCI聽+聽EGCG (II) Acute SCI聽+聽saline. (III) Chronic SCI聽+聽EGCG. (IV) Chronic SCI聽+聽saline and, sham SCI animals. EGCG i.v. treatment of acute and, chronic SCI animals resulted in significantly better recovery of motor and sensory functions, BBB and LSS (P聽<聽0.005) and (P聽<聽0.05) respectively. Tactile allodynia, mechanical nociception (P聽<聽0.05) significantly improved. Paw withdrawal and, tail flick latencies increase significantly (P聽<聽0.05). Moreover, in the EGCG treated acute SCI animals the percentage of lesion size area significantly reduced (P聽<聽0.0001) and, the number of neurons in the spinal cord increased (P聽<聽0.001). Percent areas of GAP-43 and GFAP immunohistochemistry showed significant (P聽<聽0.05) increase. We conclude that the therapeutic window of opportunity for EGCG to depict neurological recovery in SCI animals, is viable up to one year post SCI when intravenously infused for 36聽h.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700